Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Japan
  4. Japan Exchange
  5. Japan Tobacco Inc.
  6. News
  7. Summary
    2914   JP3726800000

JAPAN TOBACCO INC.

(2914)
  Report
SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Japan Tobacco : JT Terminates Exclusive License Agreement with EirGen Pharma for Calcifediol Extended-release Capsules (JTT-762)

05/25/2021 | 02:03am EDT

FOR IMMEDIATE RELEASE

Tokyo, May 25, 2021

JT Terminates Exclusive License Agreement with EirGen Pharma for Calcifediol

Extended-release Capsules (JTT-762)

Japan Tobacco Inc. (JT) (TSE:2914) announced today that the company will discontinue the development of JTT-762 (RAYALDEE® Calcifediol Extended-release Capsules). JT also announced the termination of the license agreement with EirGen Pharma Ltd. (EirGen Pharma) .

JTT-762 is a novel extended-release formulation of the prohormone of calcitriol, the active form of vitamin D3, which is approved to treat secondary hyperparathyroidism (SHPT) in adults with stage 3 or 4 chronic kidney disease (CKD) and vitamin D insufficiency in the U.S. and 11 European countries. JT's decision to discontinue development of JTT-762 follows a comprehensive reconsideration of its development pipeline.

The effects of this termination of the exclusive license agreement on JT's business performance in this fiscal year will be immaterial.

About EirGen Pharma Ltd.

EirGen Pharma Ltd., established in 2005, is a world-leader in the development, registration, manufacturing and supply of high-potency pharmaceutical products to global markets. The company is headquartered Waterford, Ireland.

For more information, visit www.eirgen.com.

###

Japan Tobacco Inc. is a leading international tobacco company with operations in more than 130 countries. With approximately 58,000 employees, it manufactures and sells some of the world's best-known brands including Winston, Camel, MEVIUS and LD. The JT Group is committed to investing in Reduced-Risk Products (RRP) and currently markets its heated tobacco products under the Ploom brand and various e-cigarette products under its Logic brand. The Group is also present in the pharmaceutical and processed food businesses.

For more information, visit https://www.jt.com/.

Contact for Japan Tobacco Inc.:

Dinesh Babu Thotakura, General Manager

Media and Investor Relations Division

Japan Tobacco Inc. Tokyo: +81-3-6636-2026

E-mail: jt.media.relations@jt.com

Disclaimer

Japan Tobacco Inc. published this content on 25 May 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 25 May 2021 06:02:01 UTC.


© Publicnow 2021
All news about JAPAN TOBACCO INC.
07/15JAPAN TOBACCO : C O R R E C T I O N -- Japan Tobacco Inc./
AQ
07/15JAPAN TOBACCO : JT Group launches Ploom X - The next generation heated to..
PU
07/15JAPAN TOBACCO : JT launches Ploom X, the next generation heated tobacco device
PU
07/15JAPAN TOBACCO : JT Group launches Ploom X
AQ
07/15Japan Tobacco Inc. Launches Ploom X
CI
06/29JAPAN TOBACCO INC. : Ex-dividend day for interim dividend
FA
06/18JAPAN TOBACCO : (Updated)Integrated Report 2020
PU
06/16JAPAN TOBACCO : JT Group's Human Rights Report marks ten years of contributions ..
PU
05/26Japan Tobacco Issues Shares as Part of Stock Compensation Plan
MT
05/26JAPAN TOBACCO : Listing on the Japanese National Health Insurance Drug Price Lis..
PU
More news
Financials
Sales 2021 2 161 B 19 547 M 19 547 M
Net income 2021 272 B 2 461 M 2 461 M
Net Debt 2021 502 B 4 541 M 4 541 M
P/E ratio 2021 13,8x
Yield 2021 6,04%
Capitalization 3 828 B 34 632 M 34 620 M
EV / Sales 2021 2,00x
EV / Sales 2022 1,93x
Nbr of Employees 58 300
Free-Float 54,5%
Chart JAPAN TOBACCO INC.
Duration : Period :
Japan Tobacco Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends JAPAN TOBACCO INC.
Short TermMid-TermLong Term
TrendsNeutralBullishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 14
Last Close Price 2 157,50 JPY
Average target price 2 281,00 JPY
Spread / Average Target 5,72%
EPS Revisions
Managers and Directors
Masamichi Terabatake President, CEO & Representative Director
Naohiro Minami CFO, Representative Director & Executive VP
Yasutake Tango Chairman
Hiroyuki Miki Executive Officer, Head-Research & Development
Kazuhito Yamashita Director, Head-Compliance & General Affairs
Sector and Competitors
1st jan.Capi. (M$)
JAPAN TOBACCO INC.2.64%35 225
ALTRIA GROUP, INC.14.61%88 127
ITC LIMITED-0.96%34 042
PT HANJAYA MANDALA SAMPOERNA TBK-24.92%9 341
KT&G CORPORATION-0.24%9 323
PT GUDANG GARAM TBK-12.07%5 162